BIOMAT Database Logo BIOMAT Database Logo

Effect of age on mortality experience in patients with hypertrophic cardiomyopathy. 1997

R J Pokorski
Swiss Re, Fairfield, CT 06430, USA. J_Pokorski@swissre.com

UI MeSH Term Description Entries
D007341 Insurance Coverage by contract whereby one part indemnifies or guarantees another against loss by a specified contingency. Indemnity,Insurance Premiums,Insurance Premium,Premium, Insurance,Premiums, Insurance
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002312 Cardiomyopathy, Hypertrophic A form of CARDIAC MUSCLE disease, characterized by left and/or right ventricular hypertrophy (HYPERTROPHY, LEFT VENTRICULAR; HYPERTROPHY, RIGHT VENTRICULAR), frequent asymmetrical involvement of the HEART SEPTUM, and normal or reduced left ventricular volume. Risk factors include HYPERTENSION; AORTIC STENOSIS; and gene MUTATION; (FAMILIAL HYPERTROPHIC CARDIOMYOPATHY). Cardiomyopathy, Hypertrophic Obstructive,Cardiomyopathies, Hypertrophic,Cardiomyopathies, Hypertrophic Obstructive,Hypertrophic Cardiomyopathies,Hypertrophic Cardiomyopathy,Hypertrophic Obstructive Cardiomyopathies,Hypertrophic Obstructive Cardiomyopathy,Obstructive Cardiomyopathies, Hypertrophic,Obstructive Cardiomyopathy, Hypertrophic
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D016019 Survival Analysis A class of statistical procedures for estimating the survival function (function of time, starting with a population 100% well at a given time and providing the percentage of the population still well at later times). The survival analysis is then used for making inferences about the effects of treatments, prognostic factors, exposures, and other covariates on the function. Analysis, Survival,Analyses, Survival,Survival Analyses
D017668 Age of Onset The age, developmental stage, or period of life at which a disease or the initial symptoms or manifestations of a disease appear in an individual. Age-at-Onset,Age at Onset,Onset Age

Related Publications

R J Pokorski
Age- and gender-specific mortality rates in childhood hypertrophic cardiomyopathy.
May 2008, European heart journal,
R J Pokorski
Impact of Body Mass Index on Mortality in Hospitalized Patients With Hypertrophic Cardiomyopathy.
July 2022, The American journal of cardiology,
R J Pokorski
Factors predicting long-term mortality in patients with hypertrophic cardiomyopathy.
October 2014, Echocardiography (Mount Kisco, N.Y.),
R J Pokorski
Myocardial contraction fraction predicts mortality for patients with hypertrophic cardiomyopathy.
October 2020, Scientific reports,
R J Pokorski
[Effect of verapamil on left ventricular function in patients with hypertrophic cardiomyopathy].
July 1983, Zhonghua nei ke za zhi,
R J Pokorski
[Hypertrophic cardiomyopathy in old age].
February 1988, Casopis lekaru ceskych,
R J Pokorski
Age-related sex differences in the outcomes of patients with hypertrophic cardiomyopathy.
January 2022, PloS one,
R J Pokorski
Age-Related Features of Cardiomyocyte Ploidy in Patients with Hypertrophic Obstructive Cardiomyopathy.
May 2015, Bulletin of experimental biology and medicine,
R J Pokorski
Effect of Gender and Genetic Mutations on Outcomes in Patients With Hypertrophic Cardiomyopathy.
December 2018, The American journal of cardiology,
R J Pokorski
Effect of hypertrophy on left ventricular diastolic function in patients with hypertrophic cardiomyopathy.
January 2006, Heart international,
Copied contents to your clipboard!